Promoter demethylation mediates the expression of ZNF645, a novel cancer/testis gene |
Bai, Gang
(Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University)
Liu, Yunqiang (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University) Zhang, Hao (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University) Su, Dan (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University) Tao, Dachang (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University) Yang, Yuan (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University) Ma, Yongxin (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University) Zhang, Sizhong (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University) |
1 | Sasaki, H. and Matsui, Y. (2008) Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat. Rev. Genet. 9, 129-140. DOI ScienceOn |
2 | Jones, P. and Takai, D. (2001) The role of DNA methylation in mammalian epigenetics. Science 293, 1068-1070. DOI ScienceOn |
3 | De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F. and Boon, T. (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. U.S.A. 93, 7149-7153. DOI ScienceOn |
4 | Iguchi-Ariga, S. and Schaffner, W. (1989) CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev. 3, 612-619. DOI ScienceOn |
5 | Coral, S., Sigalotti, L., Altomonte, M., Engelsberg, A., Colizzi, F., Cattarossi, I., Maraskovsky, E., Jager, E., Seliger, B. and Maio, M. (2002) 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications. Clin. Cancer. Res. 8, 2690-2695. |
6 | Christman, J. (2002) 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 21, 5483-5495. DOI ScienceOn |
7 | James, S., Link, P. and Karpf, A. (2006) Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b. Oncogene. 25, 6975-6985. DOI ScienceOn |
8 | Coral, S., Sigalotti, L., Gasparollo, A., Cattarossi, I., Visintin, A., Cattelan, A., Altomonte, M. and Maio, M. (1999) Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR). J. Immunother 22, 16-24. DOI |
9 | Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, New York, USA. |
10 | Antequera, F. and A. Bird (1993a) CpG islands. EXS. 64, 169-185. |
11 | Antequera, F. and A. Bird (1993b) Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. U.S.A. 90, 11995-11999. DOI |
12 | Dong, X., Yang, X., Wang, Y. and Chen, W. (2004) Zincfinger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients. Br. J. Cancer 91, 1566-1570. DOI ScienceOn |
13 | Loukinov, D., Pugacheva, E., Vatolin, S., Pack, S., Moon, H., Chernukhin, I., Mannan, P., Larsson, E., Kanduri, C., Vostrov, A., Cui, H., Niemitz, E., Rasko, J., Docquier, F., Kistler, M., Breen, J., Zhuang, Z., Quitschke, W., Renkawitz, R., Klenova, E., Feinberg, A., Ohlsson, R., Morse, H. R. and Lobanenkov, V. (2002) BORIS, a novel male germline-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc. Natl. Acad. Sci. U.S.A. 99, 6806-6811. DOI ScienceOn |
14 | Lim, F., Soulez, M., Koczan, D., Thiesen, H. and Knight, J. (1998) A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene. 17, 2013-2018. DOI |
15 | Gama-Sosa, M., Slagel, V., Trewyn, R., Oxenhandler, R., Kuo, K., Gehrke, C. and Ehrlich, M. (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic. Acids. Res. 11, 6883-6894. DOI ScienceOn |
16 | del Mazo, J., Prantera, G., Torres, M. and Ferraro, M. (1994) DNA methylation changes during mouse spermatogenesis. Chromosome Res. 2, 147-152. DOI |
17 | Zhu, J. and Yao, X. (2007) Use of DNA methylation for cancer detection and molecular classification. J. Biochem. Mol. Biol. 40, 135-141. DOI |
18 | Jones, P. and Baylin, S. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428. |
19 | Hofmann, O., Caballero, O., Stevenson, B., Chen, Y., Cohen, T., Chua, R., Maher, C., Panji, S., Schaefer, U., Kruger, A., Lehvaslaiho, M., Carninci, P., Hayashizaki, Y., Jongeneel, C., Simpson, A., Old, L. and Hide, W. (2008) Genome-wide analysis of cancer/testis gene expression. Proc. Natl. Acad. Sci. U.S.A. 105, 20422-20427. DOI ScienceOn |
20 | Tajima, K., Obata, Y., Tamaki, H., Yoshida, M., Chen, Y., Scanlan, M., Old, L., Kuwano, H., Takahashi, T. and Mitsudomi, T. (2003) Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer 42, 23-33. DOI ScienceOn |
21 | Bird, A. and Wolffe, A. (1999) Methylation-induced repression-belts, braces, and chromatin. Cell. 99, 451-454. DOI ScienceOn |
22 | Cedar, H. (1988) DNA methylation and gene activity. Cell. 53, 3-4. DOI ScienceOn |
23 | Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes. Dev. 16, 6-21. DOI ScienceOn |
24 | Simpson, A., Caballero, O., Jungbluth, A., Chen, Y. and Old, L. (2005) Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 5, 615-625. DOI ScienceOn |
25 | De Smet, C., Lurquin, C., Lethe, B., Martelange, V. and Boon, T. (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19, 7327-7335. DOI |
26 | Grunwald, C., Koslowski, M., Arsiray, T., Dhaene, K., Praet, M., Victor, A., Morresi-Hauf, A., Lindner, M., Passlick, B., Lehr, H., Schäfer, S., Seitz, G., Huber, C., Sahin, U. and Türeci, O. (2006) Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer. Int. J. Cancer 118, 2522-2528. DOI ScienceOn |
27 | van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647. DOI |
28 | Sigalotti, L., Fratta, E., Coral, S., Tanzarella, S., Danielli, R., Colizzi, F., Fonsatti, E., Traversari, C., Altomonte, M. and Maio, M. (2004) Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine. Cancer Res. 64, 9167-9171. DOI ScienceOn |
29 | Scanlan, M., Gure, A., Jungbluth, A., Old, L. and Chen, Y. (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev. 188, 22-32. DOI ScienceOn |
30 | Scanlan, M., Simpson, A. and Old, L. (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4, 1. |
31 | Ross, M. and Grafham, D., et al. (2005) The DNA sequence of the human X chromosome. Nature 434, 325-337. DOI ScienceOn |